DE69428276D1 - Insulinähnlicher wachstumfaktor ii als antitumormittel - Google Patents

Insulinähnlicher wachstumfaktor ii als antitumormittel

Info

Publication number
DE69428276D1
DE69428276D1 DE69428276T DE69428276T DE69428276D1 DE 69428276 D1 DE69428276 D1 DE 69428276D1 DE 69428276 T DE69428276 T DE 69428276T DE 69428276 T DE69428276 T DE 69428276T DE 69428276 D1 DE69428276 D1 DE 69428276D1
Authority
DE
Germany
Prior art keywords
pct
antituary
insulin
agent
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69428276T
Other languages
English (en)
Other versions
DE69428276T2 (de
Inventor
Paul Schofield
Charles Rees
Anna Skottner-Lundin
Singh Bhuller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Cancer Research Campaign Technology Ltd
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd, Pharmacia AB filed Critical Cancer Research Campaign Technology Ltd
Application granted granted Critical
Publication of DE69428276D1 publication Critical patent/DE69428276D1/de
Publication of DE69428276T2 publication Critical patent/DE69428276T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/30Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69428276T 1993-05-12 1994-05-12 Insulinähnlicher wachstumfaktor ii als antitumormittel Expired - Fee Related DE69428276T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310049A GB9310049D0 (en) 1993-05-12 1993-05-12 Growth factor effects
PCT/GB1994/001030 WO1994026300A1 (en) 1993-05-12 1994-05-12 Insulin-like growth factor ii as antitumour agent

Publications (2)

Publication Number Publication Date
DE69428276D1 true DE69428276D1 (de) 2001-10-18
DE69428276T2 DE69428276T2 (de) 2002-05-16

Family

ID=10735556

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69428276T Expired - Fee Related DE69428276T2 (de) 1993-05-12 1994-05-12 Insulinähnlicher wachstumfaktor ii als antitumormittel

Country Status (13)

Country Link
US (1) US5902788A (de)
EP (1) EP0697885B1 (de)
JP (1) JPH08510230A (de)
AT (1) ATE205398T1 (de)
AU (1) AU682862B2 (de)
CA (1) CA2162594A1 (de)
DE (1) DE69428276T2 (de)
DK (1) DK0697885T3 (de)
ES (1) ES2166778T3 (de)
GB (1) GB9310049D0 (de)
NZ (1) NZ265994A (de)
PT (1) PT697885E (de)
WO (1) WO1994026300A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630168B1 (en) 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2507106B2 (ja) * 1987-12-24 1996-06-12 グロペップ プロプライエタリー リミテッド インスリン様成長因子1(igf―1)または因子2(igf―2)の類縁ペプチド
SE9101341D0 (sv) * 1991-05-03 1991-05-03 Kabi Pharmacia Ab New medicinal use
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response

Also Published As

Publication number Publication date
CA2162594A1 (en) 1994-11-24
EP0697885B1 (de) 2001-09-12
AU682862B2 (en) 1997-10-23
AU6654794A (en) 1994-12-12
ES2166778T3 (es) 2002-05-01
US5902788A (en) 1999-05-11
DE69428276T2 (de) 2002-05-16
NZ265994A (en) 2001-02-23
GB9310049D0 (en) 1993-06-30
DK0697885T3 (da) 2001-12-31
ATE205398T1 (de) 2001-09-15
JPH08510230A (ja) 1996-10-29
PT697885E (pt) 2002-03-28
EP0697885A1 (de) 1996-02-28
WO1994026300A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
NO931766L (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
AU685075B2 (en) Pharmaceutical composition for treating nicotine dependence
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
GEP20063828B (en) Methods for Treating or Preventing Skin Disorders Using CD2-Binding Agents
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE260655T1 (de) Verwendung von stickstoffhaltigen aromatischen heterozyklusderivaten zur topischen behandlung von epithelerkrankungen
DE69428276D1 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel
GEP20043231B (en) Resorcinol Composition
SE9504267D0 (sv) New therapeutic use
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ITMI922657A1 (it) Composizione terapeutica per uso rettale a base di flunisolide e/o dei relativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
NO307204B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter ved behandling av stråleskader
IL107917A0 (en) Triazoloquinazolines, their preparation and their use as medicaments

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIOVITRUM AB, STOCKHOLM, SE CANCER RESEARCH CAMPAI

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOVITRUM AB, STOCKHOLM, SE

8339 Ceased/non-payment of the annual fee